RecruitingNot ApplicableNCT07575048

Assertiveness Training for Communication Skills

Strengthening the Communication Skills of Oncology Nurses Through Virtual Reality-Based Assertiveness Training


Sponsor

Amasya University

Enrollment

60 participants

Start Date

Mar 30, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to determine the effect of virtual reality-based assertiveness training on strengthening the communication skills of oncology nurses.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Those who agree to participate in the study,
  • Those who are 18 years of age or older,
  • Those who have been working in oncology clinics for at least 6 months.

Exclusion Criteria2

  • Those who gave incomplete answers to the scales used in the study,
  • Those who have previously participated in assertiveness skills training.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAssertiveness Skills Training

The content of the Assertiveness Training is based on the assertiveness training developed by Michel and Fursland (2008). Session 1: Introduction, Welcome and Orientation, The Concept of Assertiveness; Session 2: Types of Behavior; Session 3: Assertiveness Techniques; Session 4: Dealing with Criticism; Session 5: Saying "No"; Session 6: Disappointment; Session 7: Relaxation Exercises; Session 8: Application, General Discussions and Evaluation. First, scenario-based videos will be created to develop assertiveness training skills, and these videos will be integrated into virtual reality glasses. Two videos will be created for each scenario. The first video will address a communication problem experienced by the nurse. The second video will be educational content using effective communication skills in the problem experienced by the nurse. Virtual reality applications will be conducted individually with each nurse.


Locations(1)

AmasyaU

Amasya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07575048


Related Trials